Antitrust Investigation

Top sports law expert Gabe Feldman joins Emergetic Sports to implement Project Northstar, a radical plan to solve the financial crisis in college sports.

Rinnai America promotes Perry McGuire, consolidating legal, lobbying, and HR as it battles regulations and champions 'consumer choice' in the appliance market.

After a massive breach exposed sensitive genetic data, 23andMe's Canadian settlement is final. Learn what went wrong and how to claim your share.

A parent's multi-year legal battle over financial mismanagement has ended in a landmark settlement, forcing major governance and transparency reforms.

Richtech Robotics hires top-tier auditor CBIZ, citing a strategic shift, but SEC filings reveal a prior warning about a “material weakness” in controls.

Consumers overcharged for generic drugs may get cash from a new $17.8M settlement. Find out if you're eligible and how this fits into a larger legal war.

As regulators fine major ad platforms, PropellerAds' successful ISO 27001:2022 audit reaffirms its security commitment in a data-sensitive industry.

Actelion Pharmaceuticals settles a class action lawsuit for $65M, accused of illegally blocking a cheaper generic for its life-saving hypertension drug.

BRC Group Holdings announced a major debt reduction, but a history of late filings, shareholder dilution, and high-risk bets cast a shadow on its recovery.

New research shows a telehealth model boosting GLP-1 results to over 26% weight loss, but its reliance on unapproved compounded drugs raises safety flags.

Lawyers for Tirana's detained mayor accuse a U.S.-backed anti-graft unit of due process violations, urging Washington to intervene in the high-stakes case.

A petition filed with the Dept. of Commerce alleges a major railcar firm is evading duties on parts from China and Mexico, setting up a major trade battle.

After its Alzheimer's drug failed amidst controversy, Cassava Sciences rebrands as Filana Therapeutics, betting its future on a rare epilepsy disorder.

As Capricor prepares its Q4 earnings call, all eyes are on its DMD drug Deramiocel's FDA path, financial health, and next-gen exosome technology.

Investors drop their petition over Coupang's treatment, but the US government now plans a broader trade investigation into South Korea's digital practices.

Facing volatile markets, AVAX One pushes for regulatory clarity at the DC Blockchain Summit, aiming to legitimize Avalanche for institutional investors.

A new nicotine-free pouch powered by a caffeine metabolite enters the market, led by a controversial founder aiming to redefine focus and energy.

A new poll reveals overwhelming public opposition to a federal plan to stockpile glyphosate, fueled by billions in lawsuits and a retracted safety study.

Hawaiian Electric Industries reports a dramatic financial turnaround, but the utility's path forward is defined by massive investments in grid safety and renewables.

As state attorneys general ramp up multi-state investigations, Stateside Associates brings on a seasoned expert to help clients navigate the complex landscape.